WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001005954) ANTISENSE MODULATION OF LIVER GLYCOGEN PHOSPHORYLASE EXPRESSION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/005954    International Application No.:    PCT/US2000/019019
Publication Date: 25.01.2001 International Filing Date: 12.07.2000
Chapter 2 Demand Filed:    15.02.2001    
IPC:
C07H 21/00 (2006.01), C12N 9/10 (2006.01)
Applicants: ISIS PHARMACEUTICALS, INC. [US/US]; 2292 Faraday Avenue, Carlsbad, CA 92008 (US) (For All Designated States Except US).
MONIA, Brett, P. [US/US]; (US) (For US Only).
COWSERT, Lex, M. [US/US]; (US) (For US Only)
Inventors: MONIA, Brett, P.; (US).
COWSERT, Lex, M.; (US)
Agent: LICATA, Jane, Massey; Licata & Tyrrell P.C., 66 E. Main Street, Marlton, NJ 08053 (US)
Priority Data:
09/357,071 19.07.1999 US
Title (EN) ANTISENSE MODULATION OF LIVER GLYCOGEN PHOSPHORYLASE EXPRESSION
(FR) MODULATION ANTISENS DE L'EXPRESSION DE LA GLYCOGENE PHOSPHORYLASE DU FOIE
Abstract: front page image
(EN)Antisense compounds, compositions and methods are provided for modulating the expression of liver glycogen phosphorylase. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding liver glycogen phosphorylase. Methods of using these compounds for modulation of liver glycogen phosphorylase expression and for treatment of diseases associated with expression of liver glycogen phosphorylase are provided.
(FR)L'invention concerne des composés antisens, ainsi que des compositions et procédés destinés à moduler l'expression de la glycogène phosphorylase du foie. Ces compositions comprennent des composés antisens, notamment des oligonucléotides antisens, dirigés sur des acides nucléiques codant pour la glycogène phosphorylase du foie. L'invention concerne également des procédés d'utilisation de ces composés dans la modulation de l'expression de la glycogène phosphorylase du foie et dans le traitement de maladies associés à l'expression de cette glycogène phosphorylase.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)